T helper (Th) cells are known to diŠerentiate into several distinct subsets depending on their environment. The Interleukin 17 (IL-17)-producing subset Th17, which was reported and named in 2005, has been extensively analyzed because a strong association with in‰ammatory disorders has been suggested. The condition in which Th17 cells are diŠerentiated, critical transcription factors, and similarity and diŠerence between mouse and human Th17 cells have been reported one after the other. IL-23, which is believed to be important for the activation of Th17 cells, and IL-17 became promising targets for drug development. In fact, biological drugs that block the IL-23/IL-17 axis have demonstrated to be highly eŠective against the in‰ammatory skin disease psoriasis and have been approved for clinical use.

